- Home
- DNUT vs BEAM Comparison
DNUT vs BEAM Comparison
Compare DNUT & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNUT
- BEAM
- Stock Information
- Founded
- DNUT 1937
- BEAM 2017
- Country
- DNUT United States
- BEAM United States
- Employees
- DNUT N/A
- BEAM N/A
- Industry
- DNUT Food Chains
- BEAM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DNUT Consumer Staples
- BEAM Health Care
- Exchange
- DNUT Nasdaq
- BEAM Nasdaq
- Market Cap
- DNUT 1.9B
- BEAM 1.9B
- IPO Year
- DNUT 2021
- BEAM 2020
- Fundamental
- Price
- DNUT $10.89
- BEAM $24.05
- Analyst Decision
- DNUT Buy
- BEAM Buy
- Analyst Count
- DNUT 9
- BEAM 11
- Target Price
- DNUT $15.44
- BEAM $45.90
- AVG Volume (30 Days)
- DNUT 1.8M
- BEAM 1.3M
- Earning Date
- DNUT 11-07-2024
- BEAM 11-05-2024
- Dividend Yield
- DNUT 1.29%
- BEAM N/A
- EPS Growth
- DNUT N/A
- BEAM N/A
- EPS
- DNUT 0.16
- BEAM N/A
- Revenue
- DNUT $1,712,279,000.00
- BEAM $349,643,000.00
- Revenue This Year
- DNUT $1.30
- BEAM N/A
- Revenue Next Year
- DNUT $6.44
- BEAM $6.04
- P/E Ratio
- DNUT $66.14
- BEAM N/A
- Revenue Growth
- DNUT 4.42
- BEAM 328.73
- 52 Week Low
- DNUT $9.18
- BEAM $20.84
- 52 Week High
- DNUT $17.84
- BEAM $49.50
- Technical
- Relative Strength Index (RSI)
- DNUT 42.25
- BEAM 46.67
- Support Level
- DNUT $10.85
- BEAM $21.46
- Resistance Level
- DNUT $11.35
- BEAM $32.29
- Average True Range (ATR)
- DNUT 0.48
- BEAM 2.04
- MACD
- DNUT -0.11
- BEAM 0.19
- Stochastic Oscillator
- DNUT 2.45
- BEAM 23.92
About DNUT Krispy Kreme Inc.
Krispy Kreme Inc is a sweet treat brands company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in- your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing ecommerce and delivery business. The company conducts its business through the following three reported segments namely U.S., includes all operations in the U.S. and Canada, Insomnia Cookies shops, and the Branded Sweet Treat Line; International includes operations in the U.K., Ireland, Australia, New Zealand, and Mexico; and Market Development includes franchise operations across the globe, as well as operations in Japan. It derives maximum revenue from U.S. Segment.
About BEAM Beam Therapeutics Inc.
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.